Anebulo Pharmaceuticals, Inc.
ANEB · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $11,628 | $3,094 | $11,247 | $14,548 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $73 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $261 | $414 | $423 | $1,031 |
| Total Curr. Assets | $11,963 | $3,508 | $11,670 | $15,579 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $183 | $565 | $0 | $0 |
| Total NC Assets | $183 | $565 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $12,146 | $4,073 | $11,670 | $15,579 |
| Liabilities | – | – | – | – |
| Payables | $224 | $156 | $535 | $381 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $104 | $534 | $132 |
| Total Curr. Liab. | $224 | $261 | $1,069 | $513 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $264 | $0 | -$0 | $0 |
| Total NC Liab. | $264 | $0 | -$0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $488 | $261 | $1,069 | $513 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $41 | $26 | $26 | $23 |
| Retained Earnings | -$73,889 | -$65,404 | -$57,202 | -$45,470 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $85,505 | $69,190 | $67,778 | $60,513 |
| Total Equity | $11,658 | $3,813 | $10,601 | $15,067 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $12,146 | $4,073 | $11,670 | $15,579 |
| Net Debt | -$11,628 | -$3,094 | -$11,247 | -$14,548 |